Apyx Medical Q1 EPS $(0.22) Misses $(0.20) Estimate, Sales $10.24M Beat $9.53M Estimate
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical reported Q1 earnings with a loss of $(0.22) per share, missing the $(0.21) estimate, and sales of $10.24M, beating the $9.53M estimate. This represents a 120% increase in losses and a 15.63% decrease in sales from the previous year.
May 09, 2024 | 11:17 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Apyx Medical's Q1 earnings showed a larger loss per share than expected but exceeded sales forecasts.
The mixed results with a miss on EPS but a beat on revenue could lead to neutral market reaction. The increased loss may concern investors, but the sales beat indicates some operational strengths.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100